中文速读
本研究使用Entranster-in vivo体内转染试剂,通过尾静脉注射将ONFH-exos或NOR-exos递送至大鼠体内,探究外泌体对非创伤性股骨头坏死的影响,发现ONFH-exos可诱导GC诱导的ONFH样损伤,而NOR-exos具有保护作用。
大鼠尾静脉骨C3H10T1/2HMSCs
CD41-deficient exosomes from non-traumatic femoral head necrosis tissues impair osteogenic differentiation and migration of mesenchymal stem cells
Weiwen Zhu 1 , MinKang Guo 1 , Wu Yang 1 , Min Tang 2 , Tingmei Chen 2 , Delu Gan 2 , Dian Zhang 2 , Xiaojuan Ding 3 , Anping Zhao 1 , Pei Zhao 1 , Wenlong Yan 1 , Jian Zhang 4 Affiliations
- PMID: 32341357
- PMCID: PMC7184624
- DOI: 10.1038/s41419-020-2496-y
Free PMC article
Abstract
Non-traumatic osteonecrosis of the femoral head (ONFH) is clinically a devastating and progressive disease without an effective treatment. Mesenchymal stem cells (MSCs) transplantation has been used to treat ONFH in early stage, but the failure rate of this therapy is high due to the reduced osteogenic differentiation and migration of the transplanted MSCs related with pathological bone tissues. However, the mechanism responsible for this decrease is still unclear. Therefore, we assume that the implanted MSCs might be influenced by signals delivered from pathological bone tissue, where the exosomes might play a critical role in this delivery. This study showed that exosomes from ONFH bone tissues (ONFH-exos) were able to induce GC-induced ONFH-like damage, in vivo and impair osteogenic differentiation and migration of MSCs, in vitro. Then, we analyzed the differentially expressed proteins (DEPs) in ONFH-exos using proteomic technology and identified 842 differentially expressed proteins (DEPs). On the basis of gene ontology (GO) enrichment analysis of DEPs, fold-changes and previous report, cell adhesion-related CD41 (integrin α2b) was selected for further investigation. Our study showed that the CD41 (integrin α2b) was distinctly decreased in ONFH-exos, compared to NOR-exos, and downregulation of CD41 could impair osteogenic differentiation and migration of the MSCs, where CD41-integrin β3-FAK-Akt-Runx2 pathway was involved. Finally, our study further suggested that CD41-affluent NOR-exos could restore the glucocorticoid-induced decline of osteogenic differentiation and migration in MSCs, and prevent GC-induced ONFH-like damage in rat models. Taken together, our study results revealed that in the progress of ONFH, exosomes from the pathological bone brought about the failure of MSCs repairing the necrotic bone for lack of some critical proteins, like integrin CD41, and prompted the progression of experimentally induced ONFH-like status in the rat. CD41 could be considered as the target of early diagnosis and therapy in ONFH.
小核酸转染试剂Entranster™-R4000 已有 223 篇已发表文献
同类研究
- Front Endocrinol (Lausanne). 2025 May 2:16:1556310.doi: 10.3389/fendo.2025.1556310. eCollection 2025. Ameliorative effec…
- Cardiovasc Diabetol. 2024 Dec 21;23(1):452.doi: 10.1186/s12933-024-02545-z. ANXA1-FPR2 axis mitigates the susceptibility…
- Exp Brain Res. 2024 Jan;242(1):33-45.doi: 10.1007/s00221-023-06682-x. Epub 2023 Nov 6. MicroRNA-124 conducts neuroprotec…
- J Physiol. 2024 Jan;602(2):317-332.doi: 10.1113/JP283960. Epub 2023 Dec 28. miR-22-3p in the rostral ventrolateral medul…
- Discov Med. 2023 Aug;35(177):576-589.doi: 10.24976/Discov.Med.202335177.58. H2S Alleviates Propofol-Induced Impaired Lea…